
DTIL
Healthcare · Biotechnology · $288.8M market cap
$7.57-0.47 (-5.9%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +10.6% over 90 days · 30-day revisions 1 up, 2 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 3, 2026 | Before the open | -1.02 | -0.65 | +36.3% |
| Aug 6, 2026 | Before the open | -0.74 | -0.71 | +4.1% |
| May 5, 2026 | Before the open | -0.81 | -0.75 | +7.4% |
| Mar 12, 2026 | Time not confirmed | -0.64 | 1.01 | +256.4% |
| Nov 3, 2025 | Before the open | -2.21 | -1.84 | +16.7% |
| Aug 7, 2025 | Before the open | -0.09 | -2.13 | -2266.7% |
| May 15, 2025 | Before the open | -0.43 | -2.21 | -414.0% |
| Mar 25, 2025 | Before the open | -2.94 | -2.14 | +27.5% |
| Nov 4, 2024 | Before the open | -3.13 | -2.25 | +28.1% |
| Aug 1, 2024 | Before the open | -5.07 | 4.67 | +192.1% |
| May 13, 2024 | Before the open | -1.91 | 1.70 | +189.0% |
| Mar 27, 2024 | Before the open | -2.05 | -4.06 | -98.0% |
| Nov 7, 2023 | Before the open | -5.00 |
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular…
| -2.10 |
| +58.0% |
| Aug 4, 2023 | Before the open | -7.50 | -3.00 | +60.0% |
| May 9, 2023 | Before the open | -6.60 | -6.55 | +0.8% |
| Mar 9, 2023 | Before the open | -0.21 | -0.26 | -23.8% |
| Nov 8, 2022 | Before the open | -11.16 | -6.60 | +40.9% |
| Aug 8, 2022 | Before the open | -13.92 | -13.80 | +0.9% |
| May 9, 2022 | Before the open | -16.20 | -13.80 | +14.8% |
| Mar 15, 2022 | Before the open | -0.47 | -0.52 | -10.6% |
| Nov 10, 2021 | Before the open | -17.71 | -5.82 | +67.1% |
| Aug 12, 2021 | Before the open | -17.07 | 10.80 | +163.3% |
| May 13, 2021 | Before the open | -16.47 | -9.90 | +39.9% |
| Mar 18, 2021 | Before the open | -0.11 | -0.44 | -300.0% |
| Nov 10, 2020 | Before the open | -20.33 | -15.00 | +26.2% |
| Aug 13, 2020 | Before the open | -18.26 | -18.90 | -3.5% |
| May 15, 2020 | Before the open | -16.00 | -15.60 | +2.5% |
| Mar 10, 2020 | Before the open | -0.48 | -0.36 | +25.0% |
| Nov 12, 2019 | Before the open | -13.58 | -12.30 | +9.4% |
| Aug 14, 2019 | After the close | -12.98 | -9.89 | +23.8% |
| Apr 29, 2019 | After the close | -11.72 | -11.40 | +2.7% |
| Mar 28, 2019 | After the close | 0.00 | 0.00 | — |
| Oct 19, 2018 | Time not confirmed | — | -0.15 | — |